https://www.healthcarein.org/news-1/nih-director-francis-collins-resigns-after-12-years 2025-03-03 https://www.healthcarein.org/news-1/fda-approves 2025-02-15 https://www.healthcarein.org/news-1/nih-cuts-'indirect-costs'-by-15%25 2025-02-15 https://www.healthcarein.org/news-1/itovebi-approved-for-metastatic-breast-cancer 2024-10-14 https://www.healthcarein.org/news-1/fda-approves-novartis'-kisqali-for-breast-cancer 2024-09-18 https://www.healthcarein.org/news-1/astrazeneca's-imfinzi-approved-for-cancer 2024-08-14 https://www.healthcarein.org/news-1/complications-arise-from-car-t-cell-therapy---fda 2024-07-12 https://www.healthcarein.org/news-1/ftc-to-charge-pbms-on-high-costs-of-medicines 2024-07-11 https://www.healthcarein.org/news-1/eli-lilly-approaches-%24900-b-valuation 2024-07-11 https://www.healthcarein.org/news-1/fda-stops-novo-nordisk's-latest-drug 2024-07-11 https://www.healthcarein.org/news-1/eli-lilly's-new-obesity-drug-is-showing-promise 2024-07-11 https://www.healthcarein.org/news-1/fda-approves-merck's-sotatercept 2024-07-11